
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Rhein is an anthraquinone compound found in rhubarb and other plants that exhibits hepatoprotective and anti-inflammatory properties. It works primarily through inhibition of NF-κB signaling pathways and modulation of oxidative stress markers.

Origin & History

Rhein is an anthraquinone compound naturally obtained from rhubarb species (Rheum undulatum and Rheum palmatum) and Cassia reticulata, where it commonly exists as glycosides such as rhein-8-glucoside. First isolated in 1895, this orange crystalline compound has been detected in various foods including docks (Rumex) and garden rhubarbs.
Research Narrative (Provisional)
The available research indicates that 'a significant number of articles have been published on Rhein,' but specific human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs with detailed study designs and outcomes are not provided in the current research dossier. Additional peer-reviewed sources would be necessary to detail specific clinical evidence.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Rhein (Anthraquinone) is a pure bioactive compound (C15H8O6, molecular weight 284.22 g/mol), not a food ingredient, therefore it has no macronutrient, vitamin, or mineral profile. It is a 1,8-dihydroxyanthraquinone-3-carboxylic acid derivative. As a compound, it is 100% the active molecule with no caloric value in pharmacological use. Bioactive concentration: found naturally in rhubarb (Rheum species) at approximately 0.1–1.2 mg/g dry weight, in Cassia species at 0.05–0.8 mg/g, and in Polygonum multiflorum at 0.2–0.9 mg/g. Oral bioavailability is estimated at 20–30% in animal models, significantly limited by first-pass metabolism and poor aqueous solubility (approximately 0.03 mg/mL in water). It undergoes glucuronidation and sulfation in the intestine and liver. Peak plasma concentration (Tmax) occurs at approximately 1–2 hours post-oral administration. Protein binding is high (>90%, primarily albumin). It is partially converted from its prodrug form rheinanthrone by gut microbiota. Log P value is approximately 1.76, indicating moderate lipophilicity. No dietary fiber, protein, fat, or carbohydrate content is applicable as this is an isolated phytochemical compound.
Reported Mechanism (Provisional)
Rhein inhibits nuclear factor-κB (NF-κB) signaling pathways, reducing production of pro-inflammatory cytokines like TNF-α and IL-6. The compound also activates Nrf2-mediated antioxidant response elements, enhancing glutathione peroxidase and superoxide dismutase activity. Additionally, rhein modulates apoptotic pathways by regulating Bcl-2 and Bax protein expression ratios.
Clinical Narrative (Provisional)
Most research on rhein consists of in vitro and animal studies, with limited human clinical trials available. Animal studies using doses of 25-100 mg/kg have shown significant hepatoprotective effects against drug-induced liver injury. In vitro studies demonstrate anti-cancer activity against various cell lines at concentrations of 10-50 μM. The evidence quality remains preliminary, requiring more robust human clinical trials to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







